期刊文献+

复方苦参注射液联合FOLFOX4方案治疗晚期结直肠癌的临床效果观察 被引量:5

Clinical Effect of Compound Matrine Injection Combined With FOLFOX4 Regimen in the Treatment of Advanced Colorectal Cancer
下载PDF
导出
摘要 目的观察复方苦参注射液联合FOLFOX4化疗方案治疗晚期结直肠癌的临床效果。方法选取我院2012年6月~2015年5月化疗的90例晚期结直肠癌患者为研究对象,依据治疗方法分为照组45例(FOLFOX4化疗)和观察组45例(复方苦参注射液+FOLFOX4化疗),4个疗程结束后,统计分析两组的治疗效果和生存情况。结果两组中均未见完全缓解病例,观察组临床总有效率(64.44%)以及1年生存率(17.78%)高于对照组,P〈0.05,差异具有统计学意义。结论复方苦参注射液联合FOLFOX4化疗有利于改善晚期结直肠癌治疗效果,延长生存时间。 Objective To observe the clinical effect of compound kushen injection combined with FOLFOX4 for the treatment of advanced colorectal cancer.Methods 90 cases with advanced colorectal cancer were selected in our hospital from June 2012 to May 2015. According to the treatment methods, they were divided into control group of 45 cases (FOLFOX4 chemotherapy) and observation group of 45 cases (compound kushen injection combined with FOLFOX4). The treatment effect and survival rate of the two groups were statistically analyzed after 4 period of treatment.ResultsThere was no complete remission in the two groups, the clinical total effective rate (64.44%) and the 1 year survival rate (17.78%) in the observation group were signiifcantly higher than those in the control group,P〈0.05, there were signiifcant differences.Conclusion Compound kushen injection combined with FOLFOX4 chemotherapy can improve the treatment effect of advanced colorectal cancer, prolong the survival time, and it is recommended to promote.
作者 赵丽红
出处 《中国继续医学教育》 2015年第27期210-211,共2页 China Continuing Medical Education
关键词 复方苦参注射液 FOLFOX4化疗 结直肠癌 晚期 Compound kushen injection FOLFOX4 chemotherapy Colorectal cancer Advanced
  • 相关文献

参考文献3

二级参考文献23

  • 1赵善黎,曾宝珠,沈慧.复方苦参注射液联合放化疗治疗恶性肿瘤64例[J].中医研究,2007,20(8):44-45. 被引量:4
  • 2Kim JY, Kim YJ, Lee KW, et al. Practical outcome of adjuvant FOLFOX4 chemotherapy in elderly patients with stage III colon cancer: single-center study in Korea [ J ]. Jpn J Clin Oncol, 2013, 43 : 132-138.
  • 3Moreau LC, Rajan R, Thirlwell MP, et al. Response to chemo- therapy in metastatic colorectal eancer after exposure to oxalipla- tin in the adjuvant setting [ J]. Antieaneer Res, 2013, 33: 1765-1768.
  • 4Zhou SW, Huang YY, Wei Y, et al. No survival benefit from adding cetuximab or panitumumab to oxaliplatin-based chemo- therapy in the first-line treatment of metastatic colorectal cancer in KRAS wild type patients : a meta-analysis [ J ]. P LoS One, 2012, 7 :e50925.
  • 5Ono T, Ishida H, Kumamoto K, et al. Outcome in disappearing colorectal cancer liver metastases during oxaliplatin-based chem- otherapy [ J]. Oncol Lett, 2012, 4:905-909.
  • 6Liang L, Wang XY, Zhang XH, et al. Sophoridine exerts an an- ti-colorectal carcinoma effect through apoptosis induction in vitro and in vivo [J]. Life Sci, 2012, 91:1295-1303.
  • 7Ho JW, Ngan Hon PL, Chim WO. Effects of oxymatrine from Ku Shen on cancer cells [ J ]. Anticancer Agents Med Chem, 2009, 9:823-826.
  • 8李敏,钱晓萍,刘宝瑞.奥沙利铂联合复方苦参注射液抗血管生成作用的实验研究[J].中国癌症杂志,2008,18(3):167-171. 被引量:51
  • 9徐永强,周静,杜兵,刘长宝.参附注射液对晚期结直肠癌化疗患者血细胞的影响[J].中国中医急症,2010,19(1):66-68. 被引量:11
  • 10王红梅,刘士欣,廖国清.复方苦参注射液联合化疗治疗晚期结肠癌临床观察[J].中国医院用药评价与分析,2010,10(5):461-462. 被引量:15

共引文献28

同被引文献26

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部